Display options
Share it on

Int J Ophthalmol. 2017 Apr 18;10(4):507-514. doi: 10.18240/ijo.2017.04.02. eCollection 2017.

Oxidative stress affects retinal pigment epithelial cell survival through epidermal growth factor receptor/AKT signaling pathway.

International journal of ophthalmology

Xiao-Dong Chen, Ming-Yang Su, Tao-Tao Chen, Hai-Yan Hong, Ai-Dong Han, Wen-Sheng Li

Affiliations

  1. Xiamen Eye Center of Xiamen University, Xiamen University, Xiamen 361003, Fujian Province, China.
  2. Department of Ophthalmology, Xi'an No.1 Hospital, Shaanxi Institute of Ophthalmology, Shaanxi Provincial Key Laboratory of Ophthalmology, Xi'an 710002, Shaanxi Province, China.
  3. State Key Laboratory for Cellular Stress Biology, School of Life Sciences, Xiang'an Campus, Xiamen University, Xiang'an District, Xiamen 361102, Fujian Province, China.

PMID: 28503420 PMCID: PMC5406625 DOI: 10.18240/ijo.2017.04.02

Abstract

AIM: To investigate the cross-talk between oxidative stress and the epidermal growth factor receptor (EGFR)/AKT signaling pathway in retinal pigment epithelial (RPE) cells.

METHODS: Human RPE cell lines (ARPE-19 cell) were treated with different doses of epidermal growth factor (EGF) and hydrogen peroxide (H

RESULTS: EGF treatment increased ARPE-19 cell viability and proliferation through inducing phosphorylation of EGFR and AKT. H

CONCLUSION: Oxidative stress affects RPE cell viability and proliferation through interfering with the EGFR/AKT signaling pathway. The EGFR/AKT signaling pathway may be an important target in oxidative stress-induced RPE cell dysfunction.

Keywords: AKT; epidermal growth factor receptor; oxidative stress; retinal pigment epithelial cell

References

  1. Clin Ophthalmol. 2012;6:1471-6 - PubMed
  2. Mol Vis. 2016 Aug 12;22:1015-23 - PubMed
  3. J Ocul Pharmacol Ther. 2010 Aug;26(4):309-14 - PubMed
  4. Cell. 2010 Jun 25;141(7):1117-34 - PubMed
  5. Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34 - PubMed
  6. Development. 2005 Sep;132(18):4017-27 - PubMed
  7. Int J Mol Sci. 2014 Oct 17;15(10):18762-75 - PubMed
  8. Trends Cell Biol. 2016 May;26(5):352-66 - PubMed
  9. Exp Eye Res. 2004 Jul;79(1):51-9 - PubMed
  10. Prog Retin Eye Res. 2000 Mar;19(2):205-21 - PubMed
  11. Biochem Pharmacol. 2016 Mar 1;103:129-39 - PubMed
  12. Lancet Glob Health. 2014 Feb;2(2):e106-16 - PubMed
  13. Physiol Rev. 2005 Jul;85(3):845-81 - PubMed
  14. J Biol Chem. 2000 May 12;275(19):14624-31 - PubMed
  15. Ophthalmic Res. 2012;47(4):171-88 - PubMed
  16. Invest Ophthalmol Vis Sci. 2016 Feb;57(2):360-71 - PubMed
  17. Exp Eye Res. 2008 Oct;87(4):342-8 - PubMed
  18. Biochim Biophys Acta. 2013 Aug;1830(8):4117-29 - PubMed
  19. Free Radic Res. 2013 Oct;47(10):774-80 - PubMed
  20. Ageing Res Rev. 2015 Nov;24(Pt B):286-98 - PubMed
  21. Invest Ophthalmol Vis Sci. 2006 Oct;47(10 ):4598-606 - PubMed
  22. Exp Eye Res. 2003 Apr;76(4):397-403 - PubMed
  23. Open Neurol J. 2016 Aug 31;10:83-7 - PubMed
  24. Br J Ophthalmol. 2016 Jan;100(1):122-7 - PubMed
  25. Invest Ophthalmol Vis Sci. 2007 May;48(5):2242-8 - PubMed
  26. AIMS Mol Sci. 2016;3(2):196-221 - PubMed
  27. Dev Biol. 2015 Nov 15;407(2):246-55 - PubMed
  28. PLoS One. 2012;7(11):e48501 - PubMed
  29. Redox Biol. 2016 Aug;8:24-7 - PubMed
  30. Graefes Arch Clin Exp Ophthalmol. 2001 Jan;239(1):47-52 - PubMed
  31. Ophthalmologica. 2007;221(4):244-50 - PubMed
  32. J Cell Physiol. 2006 Jan;206(1):119-25 - PubMed
  33. Arch Ophthalmol. 2004 Apr;122(4):477-85 - PubMed
  34. J Cell Mol Med. 2005 Jan-Mar;9(1):59-71 - PubMed
  35. Biochem Biophys Res Commun. 2015 Dec 25;468(4):541-7 - PubMed
  36. Ophthalmic Res. 2002 Nov-Dec;34(6):338-42 - PubMed
  37. Cell Physiol Biochem. 2015;36(6):2217-28 - PubMed
  38. Front Biosci (Schol Ed). 2013 Jan 01;5:661-71 - PubMed
  39. Life Sci. 2016 Apr 15;151:359-63 - PubMed
  40. PLoS One. 2011;6(8):e23240 - PubMed

Publication Types